id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-1327-0006,FDA,FDA-2020-E-1327,Determination of Regulatory Review Period for Purposes of Patent Extension; ADAKVEO,Notice,Determinations,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,2022-01-04T04:59:59Z,2021-11-09T19:40:14Z,2021-24070,0,0,0900006484e18049
FDA-2020-E-1327-0005,FDA,FDA-2020-E-1327,Letter to U S Patent and Trademark Office,Other,Letter(s),2021-10-22T04:00:00Z,2021,10,2021-10-22T04:00:00Z,,2021-10-26T14:37:08Z,,0,0,0900006484c0fa26
FDA-2020-E-1327-0004,FDA,FDA-2020-E-1327,Patent Term Extension Letter from Office of Patent Legal Administration to FDA CDER,Other,Letter(s),2021-07-26T04:00:00Z,2021,7,2021-07-26T04:00:00Z,,2021-07-26T17:27:38Z,,0,0,0900006484c0f931